Global Rush for Trump-Backed Virus Drug Sparks India Export Ban
- Move comes as malaria drug has seen a global run on supplies
- Small study finds drug no better than normal virus care
This article is for subscribers only.
India banned exports of a malaria drug backed by U.S. President Donald Trump amid a run on supplies globally, even as scientists continue to search for conclusive evidence of the medicine’s effectiveness against the novel coronavirus.
Exports of hydroxychloroquine will be limited to fulfilling fully paid existing contracts, while certain shipments on humanitarian grounds may also be allowed on a case-by-case basis, according to a statement issued Wednesday by the Directorate General of Foreign Trade. The ban also does not apply to factories in its special economic zones.